135 related articles for article (PubMed ID: 26194868)
1. Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study.
Haruta H; Hiro T; Mitsumata M; Takayama T; Sudo M; Li Y; Takahashi R; Taniguchi Y; Shiomi M; Hirayama A
J Cardiol; 2016 Feb; 67(2):205-11. PubMed ID: 26194868
[TBL] [Abstract][Full Text] [Related]
2. Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits.
Suzuki H; Kobayashi H; Sato F; Yonemitsu Y; Nakashima Y; Sueishi K
J Atheroscler Thromb; 2003; 10(2):109-16. PubMed ID: 12740485
[TBL] [Abstract][Full Text] [Related]
3. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.
Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Terashima M; Michishita I
Am Heart J; 2012 Feb; 163(2):191-9.e1. PubMed ID: 22305836
[TBL] [Abstract][Full Text] [Related]
4. Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque.
Takashima H; Ozaki Y; Yasukawa T; Waseda K; Asai K; Wakita Y; Kuroda Y; Kosaka T; Kuhara Y; Ito T
Circ J; 2007 Nov; 71(11):1678-84. PubMed ID: 17965484
[TBL] [Abstract][Full Text] [Related]
5. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound--the TOGETHAR trial.
Kodama K; Komatsu S; Ueda Y; Takayama T; Yajima J; Nanto S; Matsuoka H; Saito S; Hirayama A
Circ J; 2010 Sep; 74(9):1922-8. PubMed ID: 20625215
[TBL] [Abstract][Full Text] [Related]
6. Effect of the dipeptidyl peptidase-4 inhibitor linagliptin on atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits: iMap-IVUS and pathological analysis.
Kurosawa T; Li Y; Sudo M; Haruta H; Hagikura K; Takayama T; Hiro T; Shiomi M; Hao H; Matsumoto T; Hirayama A; Okumura Y
Heart Vessels; 2021 Jan; 36(1):127-135. PubMed ID: 32914346
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits.
Sudo M; Li Y; Hiro T; Takayama T; Mitsumata M; Shiomi M; Sugitani M; Matsumoto T; Hao H; Hirayama A
Atherosclerosis; 2017 Oct; 265():283-291. PubMed ID: 28693828
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
Shiomi M; Koike T; Ito T
Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
[TBL] [Abstract][Full Text] [Related]
10. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
11. Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound.
Iwata A; Miura S; Imaizumi S; Zhang B; Saku K
J Cardiol; 2007 Oct; 50(4):229-34. PubMed ID: 17987838
[TBL] [Abstract][Full Text] [Related]
12. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.
Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J
JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
[TBL] [Abstract][Full Text] [Related]
14. Forty-eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas.
Zhou X; Wu L; Chen Y; Xiao H; Huang X; Li Y; Xiao H; Cao X
J Diabetes Investig; 2021 Jul; 12(7):1278-1286. PubMed ID: 33289308
[TBL] [Abstract][Full Text] [Related]
15. Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits.
Iwata A; Miura S; Zhang B; Imaizumi S; Uehara Y; Shiomi M; Saku K
Atherosclerosis; 2011 Oct; 218(2):300-7. PubMed ID: 21696737
[TBL] [Abstract][Full Text] [Related]
16. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
17. Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy.
Takayama T; Hiro T; Ueda Y; Saito S; Kodama K; Komatsu S; Hirayama A
Heart Vessels; 2015 Mar; 30(2):169-76. PubMed ID: 24463843
[TBL] [Abstract][Full Text] [Related]
18. Effect of pitavastatin and atorvastatin on regression of atherosclerosis assessed using intravascular ultrasound: a meta-analysis.
Liu H; Zhang M; Li D; Tian J; Wang X; Pan J; Liu D; Li X; An F
Coron Artery Dis; 2018 Sep; 29(6):459-468. PubMed ID: 29738341
[TBL] [Abstract][Full Text] [Related]
19. Pitavastatin: an overview.
Saito Y
Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
[TBL] [Abstract][Full Text] [Related]
20. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
da Silva PM
Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
